0	1	[	[	(
1	9	Hormonal	hormonal	JJ
10	19	metabolic	metabolic	JJ
20	26	status	status	NN
27	29	in	in	IN
30	36	breast	breast	NN
37	43	cancer	cancer	NN
44	52	patients	patient	NNS
53	58	after	after	IN
59	71	conservative	conservative	JJ
72	79	surgery	surgery	NN
79	80	:	:	:
81	91	comparison	comparison	NN
92	96	with	with	IN
97	102	known	known	JJ
103	113	prognostic	prognostic	JJ
114	122	criteria	criterion	NNS
122	123	]	]	)
125	129	Body	Body	NNP
130	136	weight	weight	NN
136	137	,	,	,
138	142	body	body	NN
143	147	mass	mass	NN
148	153	index	index	NN
153	154	,	,	,
155	159	body	body	NN
160	163	fat	fat	NN
163	164	,	,	,
165	169	lean	lean	JJ
170	174	body	body	NN
175	179	mass	mass	NN
179	180	,	,	,
181	194	blood-glucose	blood-glucose	NN
194	195	,	,	,
196	207	cholesterol	cholesterol	NN
207	208	,	,	,
209	224	HDL-cholesterol	HDL-cholesterol	NNP
224	225	,	,	,
226	238	triglyceride	triglyceride	NN
238	239	,	,	,
240	257	beta-lipoproteins	beta-lipoprotein	NNS
257	258	,	,	,
259	266	insulin	insulin	NN
266	267	,	,	,
268	280	gonadotropin	gonadotropin	NN
280	281	,	,	,
282	291	estradiol	estradiol	NN
291	292	,	,	,
293	305	testosterone	testosterone	NN
305	306	,	,	,
307	311	SHBG	SHBG	NNP
311	312	,	,	,
313	315	T3	T3	NNP
315	316	,	,	,
317	319	T4	t4	NN
320	323	and	and	CC
324	327	TSH	tsh	NN
328	334	levels	level	NNS
335	337	as	as	RB
338	342	well	well	RB
343	345	as	as	IN
346	355	estradiol	estradiol	NN
356	359	and	and	CC
360	372	progesterone	progesterone	NN
373	381	receptor	receptor	NN
382	388	levels	level	NNS
389	391	in	in	IN
392	399	excised	excise	VBN
400	405	tumor	tumor	NN
406	410	were	be	VBD
411	418	studied	study	VBN
419	421	in	in	IN
422	424	40	40	CD
425	433	patients	patient	NNS
434	438	with	with	IN
439	445	breast	breast	NN
446	452	cancer	cancer	NN
453	458	prior	prior	JJ
459	461	to	to	TO
462	474	conservative	conservative	JJ
475	484	treatment	treatment	NN
484	485	.	.	.

486	490	Said	say	VBN
491	505	anthropometric	anthropometric	JJ
505	506	,	,	,
507	516	metabolic	metabolic	JJ
517	520	and	and	CC
521	529	hormonal	hormonal	JJ
530	540	parameters	parameter	NNS
541	545	were	be	VBD
546	554	compared	compare	VBN
555	559	with	with	IN
560	563	the	the	DT
564	569	index	index	NN
570	572	of	of	IN
573	584	lymphocytic	lymphocytic	JJ
585	597	infiltration	infiltration	NN
598	600	of	of	IN
601	606	tumor	tumor	NN
607	615	selected	select	VBN
616	618	as	as	IN
619	620	a	a	DT
621	631	prognostic	prognostic	JJ
632	638	factor	factor	NN
638	639	.	.	.

640	641	A	a	DT
642	653	significant	significant	JJ
654	665	correlation	correlation	NN
666	673	between	between	IN
674	678	high	high	JJ
679	690	lymphocytic	lymphocytic	JJ
691	703	infiltration	infiltration	NN
704	705	(	(	(
705	708	2.5	2.5	CD
709	715	points	point	NNS
715	716	)	)	)
716	717	,	,	,
718	721	low	low	JJ
722	726	body	body	NN
727	731	mass	mass	NN
732	735	and	and	CC
736	739	fat	fat	NN
740	743	was	be	VBD
744	754	identified	identify	VBN
754	755	.	.	.

756	760	Also	also	RB
760	761	,	,	,
762	769	smoking	smoking	NN
770	781	contributed	contribute	VBD
782	784	to	to	TO
785	789	loss	loss	NN
790	792	of	of	IN
793	797	body	body	NN
798	802	mass	mass	NN
803	806	and	and	CC
807	810	fat	fat	NN
810	811	;	;	:
812	819	however	however	RB
819	820	,	,	,
821	823	it	it	PRP
824	830	caused	cause	VBD
831	842	lymphocytic	lymphocytic	JJ
843	855	infiltration	infiltration	NN
856	858	to	to	TO
859	863	rise	rise	VB
863	864	.	.	.

865	873	Moderate	moderate	JJ
874	878	body	body	NN
879	883	mass	mass	NN
883	884	,	,	,
885	895	relatively	relatively	RB
896	899	low	low	JJ
900	903	fat	fat	JJ
904	909	level	level	NN
910	913	and	and	CC
914	922	positive	positive	JJ
923	931	receptor	receptor	NN
932	938	status	status	NN
939	942	are	be	VBP
943	948	among	among	IN
949	956	factors	factor	NNS
957	959	of	of	IN
960	964	good	good	JJ
965	974	prognosis	prognosis	NN
975	977	in	in	IN
978	984	breast	breast	NN
985	991	cancer	cancer	NN
992	994	of	of	IN
995	1000	early	early	JJ
1001	1007	stages	stage	NNS
1007	1008	.	.	.